Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.Title<sup>89</sup>Zr-DFO-durvalumab PET/CT prior to durvalumab treatment in patients with recurrent or metastatic head and neck cancer.AuthorsVerhoeff, Sarah R.; van de Donk, Pim P.; Aarntzen, Erik H. J. G.; Oosting, Sjoukje F.; Brouwers, Adrienne H.; Miedema, Iris H. C.; Voortman, Jens; Menke-van der Houven van Oordt, Willemien C.; Boellaard, Ronald; Vriens, Dennis; Slingerland, Marije; Hermsen, Rick; Engen-van Grunsven, Ilse van; Heskamp, Sandra; van Herpen, Carla M. L.PublicationJournal of Nuclear Medicine, 2022, Vol 63, Issue 9, p1ISSN0161-5505Publication typeArticleDOI10.2967/jnumed.121.263470